Skip to main content
Elsevier

Annual Reports on Medicinal Chemistry

  • 1st Edition, Volume 67 - November 1, 2026
  • Latest edition
  • Editor: Katherine Seley-Radtke
  • Language: English

Annual Reports in Medicinal Chemistry Vol 67 provides timely and critical reviews of important topics in medicinal chemistry with an emphasis on emerging topics in the biolog… Read more

Spring sale

Nurture your knowledge

Grow your expertise with up to 25% off trusted resources*

Shop the spring sale

Description

Annual Reports in Medicinal Chemistry Vol 67 provides timely and critical reviews of important topics in medicinal chemistry with an emphasis on emerging topics in the biological sciences that are expected to provide the basis for entirely new future therapies.

Key features

  • Contributions from leading authorities
  • Informs and updates on all the latest developments in the field

Readership

Ideally suited for chemists engaged in multidisciplinary teams for drug discovery; this includes medicinal chemists and others involved in chemical biology and bio-organic disciplines and computational chemistry

Product details

  • Edition: 1
  • Latest edition
  • Volume: 67
  • Published: November 1, 2026
  • Language: English

About the editor

KS

Katherine Seley-Radtke

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach to nucleoside, nucleotide and heterocyclic drug discovery and development with therapeutic emphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currently used drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served as the Program Director for UMBC’s Chemistry-Biology Interface graduate training program funded by NIH since 2007. This program promotes hands on cross disciplinary research for almost 50 PhD students from four departments at UMBC and UMB. She is currently the Immediate Past President and Secretary-Elect for the International Society of Nucleosides, Nucleotides and Nucleic Acids and a Board member of the International Society for Antiviral Research. Prof. Seley-Radtke also serves as a standing member for several NIH study sections and is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy, Molecules – Chemical Biology, and Current Protocols in Chemical Biology.
Affiliations and expertise
Professor of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD, USA